{Reference Type}: Journal Article
{Title}: Clinical impact of novel CMR technology on patients with congenital heart disease. A scientific statement of the Association for European Pediatric and Congenital Cardiology (AEPC) and the European Association of Cardiovascular Imaging (EACVI) of the ESC.
{Author}: Voges I;Raimondi F;McMahon CJ;Ait-Ali L;Babu-Narayan SV;Botnar RM;Burkhardt B;Gabbert DD;Grosse-Wortmann L;Hasan H;Hansmann G;Helbing WA;Krupickova S;Latus H;Martini N;Martins D;Muthurangu V;Ojala T;van Ooij P;Pushparajah K;Rodriguez-Palomares J;Sarikouch S;Grotenhuis HB;Greil FG;
{Journal}: Eur Heart J Cardiovasc Imaging
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jul 10
{Factor}: 9.13
{DOI}: 10.1093/ehjci/jeae172
{Abstract}: Cardiovascular magnetic resonance (CMR) imaging is recommended in patients with congenital heart disease (CHD) in clinical practice guidelines as the imaging standard for a large variety of diseases. As CMR is evolving, novel techniques are becoming available. Some of them are already used clinically, whereas others still need further evaluation. In this statement the authors give an overview of relevant new CMR techniques for the assessment of CHD. Studies with reference values for these new techniques are listed in the supplement.